HUTCHMED (China) Limited

NASDAQ:HCM

Drug Manufacturers - Specialty & Generic

Healthcare
$13.99 +1.58%

+$0.16 today

Market cap
$2.44B
Beta
0.37
P/E (TTM)
46.2
EPS (TTM)
$0.05
52W Low $10.01High $19.50

Volume 0.04M

Average 0.04M

HCM Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

HUTCHMED (China) LimitedNASDAQ: HCM

Short-term Debt · Q4 FY2025 · quarter ended Dec 2025

Short-term debt rises 6.8% from a year ago

Short-term debt stood at $24.97M at the end of Q4 FY2025, up 6.8% from a year earlier. Over 3 fiscal years it compounded at +95.8% a year.

Context

  • Short-term debt amounted to 1.4% of total assets at the end of Q4 FY2025, down 0.4 pp from a year earlier.
  • Short-term debt increased in 2 of the last 3 fiscal years.

What to watch

Whether short-term debt keeps rising in the next quarterly balance sheet after a +6.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$24.97M— QoQ
Last fiscal yearDec 2025
$27.85M+19.2% YoY
Year agoDec 2024
$23.37M+6.8% since
Short-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.8%——
1 year+19.2%——
3-year CAGR+95.8%——
5-year CAGR——
10-year CAGR——

Short-term Debt history

USD · from the balance sheet

Latest · FY2025
27.85M USD
Year-over-year change
+19.2%
4-year CAGR
+0.9%

Short-term Debt vs competitors

How HCM compares with its peers on the latest reported figures

  • Peers report in different currencies, so short-term debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +6.8% is the 4th highest of 6, against a peer median of +9.1%.
  • Short-term debt amounts to 1.4% of total assets for HCM, versus a peer median of 1.3%.
HCM Competitors
Short-term Debt for HCM and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AAPGAscentage Pharma Group InternationalDec 2025CN¥1.22B CNY+58.9%+33.8%30.8%
GMABGenmab A/SJun 2026$294M USD——2.3%
ZLABZai Lab LimitedJun 2026$238.1M USD+36.4%—22.2%
BNTXBioNTech SEJun 2026€57.18M EUR+9.1%+13.2%0.3%
LEGNLegend Biotech CorporationSep 2026$44.1M USD-69.1%—2.6%
HCMHUTCHMED (China) LimitedDec 2025$24.97M USD+6.8%+95.8%1.4%
ANLAdlai Nortye Ltd.Dec 2025$24.58M USD-6.6%+80.3%71.4%
IDYAIDEAYA Biosciences, Inc.Mar 2026$350K USD——0.0%
INCYIncyte CorporationJun 2026$0 USD——0.0%
EXELExelixis, Inc.Jul 2026$0 USD——0.0%
RCUSArcus Biosciences, Inc.Jun 2026$0 USD——0.0%
Peer median (excluding HCM) —+9.1%+33.8%1.3%

Competitors are the stored peer set for HCM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents377.54M313.28M283.59M153.96M71.33M
Short-term Investments634.16M317.72M602.75M682.15M1.3B
Net Receivables147.73M126.72M150.46M167.74M147.83M
Inventory35.76M56.69M50.26M50.4M41.13M
Other Current Assets2.76M3.15M2.68M3.3M2.77M
Total Current Assets1.21B839.89M1.1B1.07B1.57B
Property, Plant & Equipment (Net)66.32M84.67M104.39M97M97.65M
Goodwill3.38M3.14M3.06M2.99M3.11M
Intangible Assets163K3.22M21K08.94M
Long-term Investments(557.68M)(243.94M)48.41M(599.39M)52.25M
Tax Assets9.4M15.37M15.46M012.66M
Other Non-current Assets639M327.1M11.59M707.04M11.15M
Total Non-current Assets160.59M189.56M182.93M207.64M185.76M
Total Assets1.37B1.03B1.28B1.27B1.75B
Account Payables41.18M71.12M36.33M42.52M45.53M
Short-term Debt26.91M3.71M31.16M23.37M27.85M
Tax Payables15.55M1.11M2.58M1.55M0
Deferred Revenue15.55M13.35M57.64M031.42M
Other Current Liabilities40.95M37.39M228.93M290.08M176.94M
Total Current Liabilities311.66M353.9M403.03M376.56M315.78M
Long-term Debt018.1M48.19M59.43M68.19M
Deferred Tax Liabilities2.77M2.71M1.48M2.99M255K
Deferred Revenue (Non-current)(2.77M)190K69.48M48.43M20.13M
Other Non-current Liabilities14.33M12.47M11.35M10.84M95.63M
Total Non-current Liabilities21.49M38.67M133.36M125.78M186.06M
Total Liabilities333.15M392.58M536.39M502.34M501.84M
Common Stock86.45M86.48M87.13M87.16M87.23M
Retained Earnings(610.33M)(971.48M)(870.87M)(833.17M)(378.64M)
Accumulated OCI5.57M(1.9M)(8.16M)(11.59M)(4.53M)
Other Stockholders Equity00000
Minority Interest52.62M26.5M12.85M11.92M13.34M
Total Equity1.04B636.87M743.39M771.85M1.25B
Total Debt38.98M27.01M86.13M89.82M97.89M
Net Debt(338.56M)(286.27M)(197.46M)(64.14M)26.56M

HUTCHMED (China) Limited

NASDAQ:HCM

Intrinsic Alpha fair value

Locked

Current Price

$13.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.